Cardiovascular risk in women: Focus on hypertension

Canadian Journal of Cardiology

Volumn 30, Issue 5, 2014, Pages 553-559

  Abramson, Beth L ^a   Melvin, Rochelle G ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANALGESIC AGENT; ANDROGEN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANTIDIURETIC AGENT; APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; ENDOTHELIN; ESTRADIOL; ESTROGEN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; SODIUM; SUPEROXIDE; TESTOSTERONE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADRENERGIC SYSTEM; AGE DISTRIBUTION; AGING; ALCOHOL CONSUMPTION; ALDOSTERONE RELEASE; ANDROGEN BLOOD LEVEL; ATTITUDE TO ILLNESS; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CANADA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; ETHNICITY; EXERCISE; FEMALE; FOOD INTAKE; GRAIN; HEALTH BEHAVIOR; HEALTH EDUCATION; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; KNOWLEDGE; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS (TOPIC); MICROALBUMINURIA; NONHUMAN; NORTH AMERICA; OBESITY; ORAL CONTRACEPTIVE USE; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL ACTIVITY; PLASMA RENIN ACTIVITY; PORTION SIZE; POSTMENOPAUSE; PREECLAMPSIA; PREVALENCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; RISK REDUCTION; SODIUM RESTRICTION; SWEDEN; SYSTEMIC VASCULAR RESISTANCE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; VASOCONSTRICTION; VASOPRESSIN RELEASE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WATER ABSORPTION;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MORBIDITY; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; WOMEN'S HEALTH; WORLD HEALTH;

EID: 84899618826     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.02.014     Document Type: Review

References (50)

1. National Heart, Lung, and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2004. Available at: Accessed March 3, 2014. https://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm.
2. Statistics Canada: Health Statistics Divison. Mortality, Summary List of Causes. 2009. Available at: Accessed March 3, 2014. http://www.statcan.gc.ca/pub/84f0209x/84f0209x2009000-eng.pdf.
3. Statistics Canada. High Blood Pressure 2010. Available at: Accessed: February 17, 2014. http://www.statcan.gc.ca/pub/82-625-x/2011001/article/11463-eng.htm.
4. National Center for Health Statistics. Health, United States, 2012: With Special Feature on Emergency Care. Hyattsville, MD, National Center for Health Statistics (US); 2013 May. Report No.: 213-1232.
5. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
6. World Health Organization. Global Health Risks: mortality and burden of disease attributable to selected major risks. 2009. Available at: Accessed March 3, 2014. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf.
7. Robitaille C., Dai S., Waters C., et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012, 184:49-56.
8. Geraci T.S., Geraci S.A. Considerations in women with hypertension. South Med J 2013, 106:434-438.
9. Bateman B.T., Shaw K.M., Kuklina E.V., et al. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One 2012, 7:e36171.
10. Ford E.S., Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007, 50:2128-2132.
11. Taddei S. Blood pressure through aging and menopause. Climacteric 2009, 12(suppl 1):36-40.
12. Ong K.L., Tso A.W., Lam K.S., Cheung B.M. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 2008, 51:1142-1148.
13. Folsom A.R., Prineas R.J., Kaye S.A., Munger R.G. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke 1990, 21:701-706.
14. Paynter N.P., Cook N.R., Everett B.M., et al. Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med 2009, 122:464-471.
15. Shimomura T., Wakabayashi I. Associations of cardiovascular risk factors with prehypertension and hypertension in women 2012, 21:345-351. Blood Press.
16. Forman J.P., Stampfer M.J., Curhan G.C. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009, 302:401-411.
17. Palatini P., Mos L., Santonastaso M., et al. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J Womens Health 2011, 20:1175-1181.
18. Samad Z., Wang T.Y., Frazier C.G., et al. Closing the gap: treating hypertension in women. Cardiol Rev 2008, 16:305-313.
19. Li C., Engström G., Hedblad B., Janzon L. Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension. J Hypertens 2006, 24:1523-1529.
20. Appel L.J., Moore T.J., Obarzanek E., et al. DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997, 336:1117-1124.
21. Carlsson A.C., Wändell P.E., de Faire U., Hellénius M.L. Risk factors associated with newly diagnosed high blood pressure in men and women. Am J Hypertens 2008, 21:771-777.
22. Parker E.D., Schmitz K.H., Jacobs D.R., Dengel D.R., Schreiner P.J. Physical activity in young adults and incident hypertension over 15 years of follow-up: the CARDIA study. Am J Public Health 2007, 97:703-709.
23. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA 1992, 267:1213-1220. The Trials of Hypertension Prevention Collaborative Research Group.
24. Abramson B. Heart Health for Canadians: The Definitive Guide 2013, 65-102. HarperCollins Canada, Toronto.
25. National Heart Lung and Blood Institute: Health Information Network. 5 steps to a healthy weight. Available at: Accessed: January 26, 2014. http://hp2010.nhlbihin.net/joinhin/news/consumer/ConsumerWtLossReality.htm.
26. Forman J.P., Rimm E.B., Stampfer M.J., Curhan G.C. Folate intake and the risk of incident hypertension among US women. JAMA 2005, 293:320-329.
27. Svetkey L.P. Management of prehypertension. Hypertension 2005, 45:1056-1061.
28. He F.J., Li J., Macgregor G.A. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013, 346:f1325.
29. Xin X., He J., Frontini M.G., et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001, 38:1112-1117.
30. Reckelhoff J.F., Fortepiani L.A. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004, 43:918-923.
31. Schunkert H., Danser A.H., Hense H.W., et al. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997, 95:39-45.
32. Ibrahim M.M. RAS inhibition in hypertension. J Hum Hypertens 2006, 20:101-108.
33. Komatsumoto S., Nara M. [Changes in the level of endothelin-1 with aging]. Nihon Ronen Igakkai Zasshi 1995, 32:664-669.
34. Lima R., Wofford M., Reckelhoff J.F. Hypertension in postmenopausal women. Curr Hypertens Rep 2012, 14:254-260.
35. Weiner C.P., Lizasoain I., Baylis S.A., et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 1994, 91:5212-5216.
36. Mansego M.L., Redon J., Marin R., et al. Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens 2008, 26:230-237.
37. Castelao J.E., Gago-Dominguez M. Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses 2008, 71:39-44.
38. Esler M., Rumantir M., Wiesner G., et al. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 2001, 14:304-309.
39. Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986, 61:1081-1090.
40. Keam S.J., Wagstaff A.J. Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive. Treat Endocrinol 2003, 2:49-70.
41. Permu P.I., Ofili E. Hypertension in women: Part I. J Clin Hypertens 2008, 10:406-410.
42. Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007, 335:974.
43. Roos N., Kieler H., Sahlin L., et al. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011, 343:d6309.
44. Klungel O.H., Stricker B.H.C., Paes A.H.P., et al. Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke 1999, 30:1312-1318.
45. Ong K.L., Cheung B.M., Man Y.B., Lau C.P., Lam K.S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007, 49:69-75.
46. Wilkins K., Gee M., Campbell N. The difference in hypertension control between older men and women. Health Rep 2012, 23:33-40.
47. Doner Lotenberg L., Clough L.C., Mackey T.A., et al. Lessons learned from a survey of the diagnosis and treatment journeys of postmenopausal women with hypertension. J Clin Hypertens 2013, 15:532-541.
48. Oparil S. Women and hypertension: what did we learn from the Women's Health Initiative?. Cardiol Rev 2006, 14:267-275.
49. James P.A., Oparil S., Carter B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014, 311:507-520.
50. Mosca L., Ferris A., Fabunmi R., Robertson R.M. American Heart Association. Tracking women's awareness of heart disease: an American Heart Association national study. Circulation 2004, 109:573-579.